What is the risk of using a leukaemia patients own blood cells to create stem cells?
There is no conceivable additional risk to using the patient’s own blood cells. Any risk of immune rejection is nullified because of a perfect tissue match. In certain cases, an allogeneic stem cell transplant is preferred to deliberately mount an immune response against host tumour cells. This latter process is facilitated by TriStem’s technology because the technology enables the production of stem cells from healthy blood donors without the need for invasive surgical procedures or anaesthesia. Consequently, this technology is donor-friendly, and increases the options available for the transplant recipient to locate a viable donor in a relatively short period of time.
